Atlas Trials

Eye Disorders Congenital

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Eye Disorders Congenital

RecordFirmDate
Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste) (NCT05176717)Laboratoires Thea2021-12-15
Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius) (NCT05158296)Laboratoires Thea2021-12-08
An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene. (NCT04855045)ProQR Therapeutics2021-03-23
Single Ascending Dose Study in Participants With LCA10 (NCT03872479)Editas Medicine, Inc.2019-09-26
Extension Study to Study PQ-110-001 (NCT03140969) (NCT03913130)Laboratoires Thea2019-05-13
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE) (NCT03913143)ProQR Therapeutics2019-04-04
Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (NCT03780257)ProQR Therapeutics2019-03-06
Natural History Study of CEP290-Related Retinal Degeneration (NCT03396042)Editas Medicine, Inc.2017-12-17

Track Eye Disorders Congenital automatically

Every clearance here is in the API, with alerts when new ones post.